We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK Agrees to Pay $14 Million to Settle Multistate Paxil Dispute
GSK Agrees to Pay $14 Million to Settle Multistate Paxil Dispute
March 31, 2006
GlaxoSmithKline (GSK) has agreed to pay states $14 million to resolve allegations it illegally blocked generic entry to the market of its antidepressant Paxil, which caused state healthcare plans to pay inflated prices for the drug.